Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : ZX-7101A
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : ZX-7101A is a novel PA inhibitor developed by Zenshine Pharma. It has broad-spectrum activity against influenza A, B and highly lethal variants of influenza viruses.
Product Name : ZX-7101A
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 13, 2023
Lead Product(s) : ZX-7101A
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : ZX-7101A
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : ZX-7101A is a novel PA inhibitor developed by Zenshine Pharma. It has broad-spectrum activity against influenza A, B and highly lethal variants of influenza viruses.
Product Name : ZX-7101A
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 16, 2023
Lead Product(s) : ZX-7101A
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable